Print page content Print
Increase text size Decrease text size
Text Size
Cerenia

Tools & Resources for Your Practice

These resources explain the value of CERENIA® (maropitant citrate) in the treatment and/or the prevention of vomiting in dogs and cats.

References

  1. Data on file, Study Report No. 1467C-6O-O1-597, 2OO5 Zoetis Inc.
  2. Data on file, Study Report No. 1982C-60-09-347, Zoetis Inc.
  3. Kynetec – Zoetis Custom Market Research: 2020 Cerenia Awareness, Trial, Usage and Diary Study. Sample: n=200 U.S. Companion Animal Veterinarians, December 2020 – January 2021
  4. de la Puente-Redondo VA, Tilt N, Rowan T, et al. Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs. AJVR. 2OO7;68:48-56.
  5. Data on file, Study Report No. 196OC-6O-O3-672, 2OO4 Zoetis Inc.
  6. Data on file, Study Report No. 5961P-36-O1-247, 2OO4 Zoetis Inc.
  7. Data on file, Study Report No. 5961P-36-O1-248, 2OO5 Zoetis Inc.
  8. de la Puente-Redondo VA, Siedek EM, Benchaoui HA, et al. The anti-emetic efficacy of maropitant (Cerenia™) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe. J Small Anim Pract. 2OO7;48:93-98.
  9. Sedlacek HS, Ramsey OS, Boucher JF, et. al. Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs. J Vet Pharmacol Ther. 2008:31533-537.
  10. Data on file, Study Report No. 1961R-6D-11-A81. 2011 Zoetis Inc.
  11. Hay Kraus BL. Efficacy of maropitant in preventing vomiting in dogs premedicated with hydromorphone. Vet Anaesth Analg. Epub 2O12 Oct 2O.
  12. Ramsey D, Fleck T, Herg Tet al. Cerenia prevents perioperative nausea and vomiting and improves recovery in dogs undergoing surgery. Inter J Appl Res Vet Med. 2014, 12: 228-237.
  13. Data on file, ZMR: Emesis360 Survey Results October 16th 2017 (v3.0)
  14. Kraus B. Cazlan C. Assessment of dog owner concern regarding peri-operative nausea and vomiting and willingness to pay for antiemetic treatment. Frontiers in Vet Science. 2019, doi: 10.3389/fvets.2019.00264.
  15. Data on file. CERENIA® (maropitant citrate) field Efficacy Study 1467C-60-0I-S97 Data Extraction and Analysis 2010. Zoetis Inc.
  16. Lesman SP. Boucher JF. Grover GS, Cox SR. Bidgood TL. The pharmacokinetics of maropitant citrate dosed orally to dogs at 2 mg/kg and 8 mg/kg once daily for 14 consecutive days. J Vet Pharmacol Ther. 2013, 36:462-470.
  17. CERENIA® (maropitant citrate): Package Insert. Injectable Solution U.S. Prescribing Information. NADA #141-263. Zoetis Inc, 2O14.
  18. CERENIA® (maropitant citrate) Freedom of Information Summary, Supplemental. NADA #141-253. May 16, 2012.
  19. Data on file, Zoetis Inc. Cerenia Motion Sickness Incidence by Symptom. 2O12.
  20. Data on file, Study Report No. 1963C-6O-O3-655, 2OO5 Zoetis Inc
  21. Data on file, Study Report No. 596OC-85-O1-246, Zoetis Inc.

CONTACT US

1-888-963-8471

Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2022 Zoetis Services LLC. All rights reserved.